COVID-19 infection in patients with sickle cell disease.
作者信息
Hussain Faiz A, Njoku Franklin U, Saraf Santosh L, Molokie Robert E, Gordeuk Victor R, Han Jin
机构信息
Section of Hematology/Oncology, Department of Medicine, Comprehensive Sickle Cell Center, University of Illinois at Chicago, Chicago, IL, USA.
Jesse Brown VA Medical Center, Chicago, IL, USA.
出版信息
Br J Haematol. 2020 Jun;189(5):851-852. doi: 10.1111/bjh.16734. Epub 2020 May 8.
Abstract
摘要
相似文献
1
COVID-19 infection in patients with sickle cell disease.镰状细胞病患者的新型冠状病毒肺炎感染
Br J Haematol. 2020 Jun;189(5):851-852. doi: 10.1111/bjh.16734. Epub 2020 May 8.
2
A Saudi family with sickle cell disease presented with acute crises and COVID-19 infection.一个患有镰状细胞病的沙特家庭出现了急性危象和新冠病毒感染。
Pediatr Blood Cancer. 2020 Sep;67(9):e28547. doi: 10.1002/pbc.28547. Epub 2020 Jul 10.
3
Plasmacytoid lymphocytes in SARS-CoV-2 infection (Covid-19).新型冠状病毒2型感染（新冠肺炎）中的浆细胞样淋巴细胞
Am J Hematol. 2020 Jul;95(7):861-862. doi: 10.1002/ajh.25834. Epub 2020 Apr 28.
4
SARS-CoV-2 infection in a highly experienced person living with HIV.一名经验丰富的HIV感染者感染了新型冠状病毒。
AIDS. 2020 Jul 1;34(8):1257-1258. doi: 10.1097/QAD.0000000000002572.
5
Survival study of hospitalised patients with concurrent COVID-19 and haematological malignancies.新冠病毒病与血液系统恶性肿瘤并存的住院患者生存研究
Br J Haematol. 2020 Jul;190(1):e16-e20. doi: 10.1111/bjh.16801. Epub 2020 May 27.
6
Severe COVID-19 infection associated with endothelial activation.严重的2019冠状病毒病感染与内皮细胞激活有关。
Thromb Res. 2020 Jun;190:62. doi: 10.1016/j.thromres.2020.04.014. Epub 2020 Apr 15.
7
COVID-19 presenting with autoimmune hemolytic anemia in the setting of underlying immune dysregulation.新型冠状病毒肺炎在潜在免疫失调背景下表现为自身免疫性溶血性贫血。
Pediatr Blood Cancer. 2020 Sep;67(9):e28382. doi: 10.1002/pbc.28382. Epub 2020 Jun 3.
8
Failure of hydroxychloroquine pre-exposure prophylaxis in COVID-19 infection? A case report.羟氯喹预处理预防新型冠状病毒肺炎感染失败？一例病例报告。
J Antimicrob Chemother. 2020 Sep 1;75(9):2706-2707. doi: 10.1093/jac/dkaa213.
9
COVID-19 and QT interval prolongation: more than just drug toxicity?新型冠状病毒肺炎与QT间期延长：仅仅是药物毒性吗？
Europace. 2020 Oct 1;22(10):1479. doi: 10.1093/europace/euaa145.
10
Impact of COVID-19 Infection on 24 Patients with Sickle Cell Disease. One Center Urban Experience, Detroit, MI, USA.新型冠状病毒肺炎感染对24例镰状细胞病患者的影响。美国密歇根州底特律市一家中心的城市经验。
Hemoglobin. 2020 Jul;44(4):284-289. doi: 10.1080/03630269.2020.1797775. Epub 2020 Jul 28.
引用本文的文献
1
Outcome of pregnancy in sickle cell anemia patients with COVID-19 infection.新冠病毒感染的镰状细胞贫血患者的妊娠结局
Asian J Transfus Sci. 2024 Jan-Jun;18(1):144-147. doi: 10.4103/ajts.ajts_164_21. Epub 2022 Sep 28.
2
Case Report: Obstetric and COVID-19-Related Morbidity and Mortality in Three Patients with Sickle Hemoglobinopathy.病例报告：三位镰状血红蛋白病患者的产科和与 COVID-19 相关的发病率和死亡率。
Am J Trop Med Hyg. 2024 Apr 23;110(6):1198-1200. doi: 10.4269/ajtmh.23-0761. Print 2024 Jun 5.
3
COVID-19 as a trigger for splenic infarction in a patient with sickle cell trait: A case report.新冠病毒病引发镰状细胞性状患者脾梗死：一例报告
Thromb Update. 2021 May;3:100047. doi: 10.1016/j.tru.2021.100047. Epub 2021 Mar 23.
4
Covid-19-induced Shocks, Access to Basic Needs and Coping Strategies.新冠疫情引发的冲击、基本需求的获取与应对策略
Eur J Dev Res. 2023 Apr 29:1-22. doi: 10.1057/s41287-023-00584-y.
5
Impact of the SARS-CoV-2 infection in individuals with sickle cell disease: an integrative review.2019冠状病毒病感染对镰状细胞病患者的影响：一项综合综述。
Front Med (Lausanne). 2023 May 2;10:1144226. doi: 10.3389/fmed.2023.1144226. eCollection 2023.
6
Avascular Necrosis of the Hip Triggered by COVID-19 Infection in a Patient with Sickle Cell Disease: A Case Report.镰状细胞病患者因新冠病毒感染引发的髋关节缺血性坏死：一例报告
J Orthop Case Rep. 2022 Jun;12(6):10-12. doi: 10.13107/jocr.2022.v12.i06.2844.
7
Blockade of endothelin-1 receptor B regulates molecules of the major histocompatibility complex in sickle cell disease.阻断内皮素-1 受体 B 可调节镰状细胞病中主要组织相容性复合体的分子。
Front Immunol. 2023 Feb 28;14:1124269. doi: 10.3389/fimmu.2023.1124269. eCollection 2023.
8
Acute kidney injury in Jamaicans with sickle cell disease hospitalized with COVID-19 infection.因新型冠状病毒肺炎感染住院的镰状细胞病牙买加患者的急性肾损伤
EJHaem. 2023 Jan 7;4(1):37-44. doi: 10.1002/jha2.636. eCollection 2023 Feb.
9
COVID-19 outcomes in sickle cell disease and sickle cell trait.COVID-19 在镰状细胞病和镰状细胞特征中的结果。
Best Pract Res Clin Haematol. 2022 Sep;35(3):101382. doi: 10.1016/j.beha.2022.101382. Epub 2022 Sep 7.
10
COVID-19 infection in patients with haematological disease - A tertiary centre experience from north India.COVID-19 感染血液病患者 - 来自印度北部的一家三级中心的经验。
Indian J Med Res. 2022 May-Jun;155(5&6):570-574. doi: 10.4103/ijmr.ijmr_1180_21.
本文引用的文献
1
Hospitalization Rates and Characteristics of Patients Hospitalized with Laboratory-Confirmed Coronavirus Disease 2019 - COVID-NET, 14 States, March 1-30, 2020.2020 年 3 月 1 日至 30 日，14 个州住院的经实验室确诊的 2019 冠状病毒病患者的住院率和特征 - COVID-NET。
MMWR Morb Mortal Wkly Rep. 2020 Apr 17;69(15):458-464. doi: 10.15585/mmwr.mm6915e3.
2
Preliminary Estimates of the Prevalence of Selected Underlying Health Conditions Among Patients with Coronavirus Disease 2019 - United States, February 12-March 28, 2020.2019 年冠状病毒病患者中某些基础健康状况的初步估计——美国，2020 年 2 月 12 日至 3 月 28 日。
MMWR Morb Mortal Wkly Rep. 2020 Apr 3;69(13):382-386. doi: 10.15585/mmwr.mm6913e2.
3
Management of sickle cell disease.镰状细胞病的管理
N Engl J Med. 1999 Apr 1;340(13):1021-30. doi: 10.1056/NEJM199904013401307.
Zotero 插件